HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Julien Ognard Selected Research

Julien Ognard Research Topics

Disease

6Ischemic Stroke
04/2023 - 01/2020
5Stroke (Strokes)
03/2024 - 01/2021
3Aneurysm (Aneurysms)
04/2023 - 01/2018
3Intracranial Aneurysm (Cerebral Aneurysm)
01/2022 - 07/2019
2Thrombosis (Thrombus)
04/2023 - 01/2023
2Cerebral Infarction
03/2023 - 01/2021
1Depressed Skull Fracture
04/2023
1Intracranial Arteriosclerosis (Cerebral Atherosclerosis)
04/2023
1Atherosclerosis
04/2023
1Neurilemmoma (Schwannoma)
08/2022
1Paraganglioma (Paragangliomas)
08/2022
1Intracranial Embolism
06/2022
1Neoplasms (Cancer)
01/2022
1Glioma (Gliomas)
01/2022
1Infarction (Infarctions)
01/2021
1Cerebral Hemorrhage
01/2021
1COVID-19
01/2020

Drug/Important Bio-Agent (IBA)

1danaparoid (Orgaran)FDA Link
06/2023
1TenecteplaseFDA Link
04/2023
1Heparin (Liquaemin)FDA LinkGeneric
04/2023
1FibrinIBA
04/2023
1Gallium-68IBA
08/2022
1Edotreotide (SMT 487)IBA
08/2022
1FluorineIBA
08/2022
1(18F)fluoroethyltyrosineIBA
01/2022
1cangrelorIBA
01/2022
1SilkFDA Link
07/2019

Therapy/Procedure

8Thrombectomy
03/2024 - 01/2020
3Punctures
06/2023 - 03/2023
3Therapeutics
04/2023 - 01/2021
3Stents
01/2022 - 01/2021
2Catheters
01/2021 - 01/2018
1Artificial Respiration (Mechanical Ventilation)
04/2023
1Radiotherapy
01/2022
1Endovascular Procedures
01/2021